Samsung Biologics to launch $1.8b all-cash bid for PolyPeptide

Samsung BioLogics Co. signage is seen behind medicine bottles on display at the company's headquarters and production facilities in Songdo district in Incheon, South Korea, on Wednesday, April 19, 2017. Photographer: SeongJoon Cho/Bloomberg